<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Atorvastatin,Atorvastatin.png,Statins,Statins,ATC code C10,Adverse drug reaction,Anatomical Therapeutic Chemical Classification System,Australia,Australian Medicines Handbook,Austria,Bile" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Atorvastatin - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Atorvastatin</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border="0" cellpadding="1" align="right" width="280">
<tr>
<td align="center" colspan="2"><a href="../../../a/t/o/Image%7EAtorvastatin-3D-vdW.png_7283.html" class="image" title=""><img src="../../../upload/shared/thumb/f/f3/Atorvastatin-3D-vdW.png/200px-Atorvastatin-3D-vdW.png" alt="" width="200" height="188" longdesc="../../../a/t/o/Image%7EAtorvastatin-3D-vdW.png_7283.html" /></a></td>
</tr>
<tr>
<td align="center" colspan="2">
<div style="font-size:medium; line-height:167%;">Atorvastatin</div>
</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Systematic (<a href="../../../i/n/t/International_Union_of_Pure_and_Applied_Chemistry_nomenclature_efd4.html" title="International Union of Pure and Applied Chemistry nomenclature">IUPAC</a>) name</b></td>
</tr>
<tr>
<td bgcolor="#EEEEEE" style="text-align: center; vertical-align: top;" colspan="2"><span style="font-size:11px">[R-(R*, R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5- (1-methylethyl)-3-phenyl-4- [(phenylamino)carbonyl]-1H- pyrrole-1-heptanoic acid</span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Identifiers</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" width="90"><a href="../../../c/a/s/CAS_registry_number_4b20.html" title="CAS registry number">CAS number</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=134523-00-5&amp;rn=1" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=134523-00-5&amp;rn=1" rel="nofollow">134523-00-5</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../a/n/a/Anatomical_Therapeutic_Chemical_Classification_System_186e.html" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></td>
<td bgcolor="#EEEEEE"><a href="../../../a/t/c/ATC_code_C10_0350.html" title="ATC code C10">C10</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=C10AA05" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=C10AA05" rel="nofollow">AA05</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../p/u/b/PubChem_a50b.html" title="PubChem">PubChem</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=60823" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=60823" rel="nofollow">60823</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../d/r/u/DrugBank_2050.html" title="DrugBank">DrugBank</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00055" class="external text" title="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00055" rel="nofollow">APRD00055</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Chemical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../c/h/e/Chemical_formula.html" title="Chemical formula">Formula</a></td>
<td bgcolor="#EEEEEE"><a href="../../../c/a/r/Carbon.html" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>33</sub><a href="../../../h/y/d/Hydrogen.html" title="Hydrogen"><span style="color: rgb(77,77,77); font-weight: bold;">H</span></a><sub>34</sub><a href="../../../f/l/u/Fluorine.html" title="Fluorine"><span style="color: rgb(66,98,98); font-weight: bold;">F</span></a><a href="../../../n/i/t/Nitrogen.html" title="Nitrogen"><span style="color: rgb(0,0,128); font-weight: bold;">N</span></a><sub>2</sub><a href="../../../o/x/y/Oxygen.html" title="Oxygen"><span style="color: rgb(116,35,35); font-weight: bold;">O</span></a><sub>5</sub><sup>&#160;</sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../m/o/l/Molecular_mass.html" title="Molecular mass">Mol. mass</a></td>
<td bgcolor="#EEEEEE">558.64</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Pharmacokinetic data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../b/i/o/Bioavailability.html" title="Bioavailability">Bioavailability</a></td>
<td bgcolor="#EEEEEE">12%</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../d/r/u/Drug_metabolism.html" title="Drug metabolism">Metabolism</a></td>
<td bgcolor="#EEEEEE"><a href="../../../l/i/v/Liver.html" title="Liver">Liver</a></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../b/i/o/Biological_half-life.html" title="Biological half-life">Half life</a></td>
<td bgcolor="#EEEEEE">14 hours</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../e/x/c/Excretion.html" title="Excretion">Excretion</a></td>
<td bgcolor="#EEEEEE"><a href="../../../b/i/l/Bile.html" title="Bile">Bile</a></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Therapeutic considerations</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../p/r/e/Pregnancy_category.html" title="Pregnancy category">Pregnancy cat.</a></td>
<td bgcolor="#EEEEEE">
<p>D<small>(<a href="../../../a/u/s/Australia.html" title="Australia">AU</a>)</small> X<small>(<a href="../../../u/n/i/United_States_09d4.html" title="United States">US</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../r/e/g/Regulation_of_therapeutic_goods.html" title="Regulation of therapeutic goods">Legal status</a></td>
<td bgcolor="#EEEEEE">
<p><a href="../../../s/t/a/Standard_for_the_Uniform_Scheduling_of_Drugs_and_Poisons_9597.html#Schedule_4_Prescription_Only_Medicine" title="Standard for the Uniform Scheduling of Drugs and Poisons">Prescription Only (S4)</a><small>(<a href="../../../a/u/s/Australia.html" title="Australia">AU</a>)</small> <a href="../../../p/r/e/Prescription_drug.html" title="Prescription drug">POM</a><small>(<a href="../../../u/n/i/United_Kingdom_5ad7.html" title="United Kingdom">UK</a>)</small> <a href="../../../p/r/e/Prescription_drug.html" title="Prescription drug"><span class="Unicode">℞</span><small>-only</small></a><small>(<a href="../../../u/n/i/United_States_09d4.html" title="United States">US</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../r/o/u/Route_of_administration.html" title="Route of administration">Routes</a></td>
<td bgcolor="#EEEEEE">oral</td>
</tr>
</table>
<p><b>Atorvastatin</b> (<a href="../../../i/n/t/International_Nonproprietary_Name_2c70.html" title="International Nonproprietary Name">INN</a>) (<a href="../../../i/n/t/International_Phonetic_Alphabet_96f8.html" title="International Phonetic Alphabet">IPA</a>: <span title="Pronunciation in IPA" class="IPA">[əˈtɔvəˌstætn]</span>), marketed under the trade name <b>Lipitor</b> and several others, is a member of the drug class known as <a href="../../../s/t/a/Statin.html" title="Statin">statins</a>, used for lowering <a href="../../../c/h/o/Cholesterol.html" title="Cholesterol">cholesterol</a>. Atorvastatin inhibits the rate-determining <a href="../../../e/n/z/Enzyme.html" title="Enzyme">enzyme</a> located in <a href="../../../l/i/v/Liver.html" title="Liver">hepatic tissue</a> that produces mevalonate, a small molecule used in the synthesis of cholesterol and other mevalonate derivatives. This lowers the amount of cholesterol produced which in turn lowers the total amount of <a href="../../../l/d/l/LDL_cholesterol_f52b.html" title="LDL cholesterol">LDL cholesterol</a>.</p>
<p>With 2005 sales of US$12.2 billion under the brand name Lipitor, it is the largest selling drug in the world.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Pharmacology"><span class="tocnumber">1</span> <span class="toctext">Pharmacology</span></a></li>
<li class="toclevel-1"><a href="#Clinical_use"><span class="tocnumber">2</span> <span class="toctext">Clinical use</span></a>
<ul>
<li class="toclevel-2"><a href="#Indications"><span class="tocnumber">2.1</span> <span class="toctext">Indications</span></a></li>
<li class="toclevel-2"><a href="#Available_forms"><span class="tocnumber">2.2</span> <span class="toctext">Available forms</span></a></li>
<li class="toclevel-2"><a href="#Adverse_effects"><span class="tocnumber">2.3</span> <span class="toctext">Adverse effects</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Patent_challenge"><span class="tocnumber">3</span> <span class="toctext">Patent challenge</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">4</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">5</span> <span class="toctext">External links</span></a></li>
<li class="toclevel-1"><a href="#Further_reading"><span class="tocnumber">6</span> <span class="toctext">Further reading</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Pharmacology" id="Pharmacology"></a></p>
<h2><span class="editsection">[<a href="../../../a/t/o/Atorvastatin.html" title="Edit section: Pharmacology">edit</a>]</span> <span class="mw-headline">Pharmacology</span></h2>
<dl>
<dd>
<div class="noprint"><i>Main article: <a href="../../../s/t/a/Statin.html" title="Statin">Statin</a></i></div>
</dd>
</dl>
<p>As with other statins, atorvastatin is a competitive <a href="../../../e/n/z/Enzyme_inhibitor.html" title="Enzyme inhibitor">inhibitor</a> of <a href="../../../h/m/g/HMG-CoA_reductase_7bc1.html" title="HMG-CoA reductase">HMG-CoA reductase</a>. Unlike most others, however, it is a completely <a href="../../../c/h/e/Chemical_synthesis.html" title="Chemical synthesis">synthetic</a> compound. HMG-CoA reductase catalyzes the reduction of <a href="../../../h/m/g/HMG-CoA_reductase_pathway_d53c.html" title="HMG-CoA reductase pathway">3-hydroxy-3-methylglutaryl-coenzyme A</a> (HMG-CoA) to <a href="../../../m/e/v/Mevalonate.html" title="Mevalonate">mevalonate</a>, which is the <a href="../../../r/a/t/Rate-determining_step.html" title="Rate-determining step">rate-limiting step</a> in hepatic <a href="../../../c/h/o/Cholesterol.html" title="Cholesterol">cholesterol</a> biosynthesis. Inhibition of the enzyme decreases <i><a href="../../../d/e/_/De_novo.html" title="De novo">de novo</a></i> cholesterol synthesis, increasing expression of low-density lipoprotein receptors (<a href="../../../l/d/l/LDL_receptor_072b.html" title="LDL receptor">LDL receptors</a>) on <a href="../../../h/e/p/Hepatocyte.html" title="Hepatocyte">hepatocytes</a>. This increases LDL uptake by the hepatocytes, decreasing the amount of LDL-cholesterol in the blood. Like other statins, atorvastatin also reduces blood levels of <a href="../../../t/r/i/Triglyceride.html" title="Triglyceride">triglycerides</a> and slightly increases levels of <a href="../../../h/i/g/High_density_lipoprotein.html" title="High density lipoprotein">HDL-cholesterol</a>.</p>
<p><a name="Clinical_use" id="Clinical_use"></a></p>
<h2><span class="editsection">[<a href="../../../a/t/o/Atorvastatin.html" title="Edit section: Clinical use">edit</a>]</span> <span class="mw-headline">Clinical use</span></h2>
<p><a name="Indications" id="Indications"></a></p>
<h3><span class="editsection">[<a href="../../../a/t/o/Atorvastatin.html" title="Edit section: Indications">edit</a>]</span> <span class="mw-headline">Indications</span></h3>
<p>Atorvastatin is indicated as an adjunct to diet for the treatment of <a href="../../../d/y/s/Dyslipidaemia.html" title="Dyslipidaemia">dyslipidaemia</a>, specifically <a href="../../../h/y/p/Hypercholesterolaemia.html" title="Hypercholesterolaemia">hypercholesterolaemia</a>. It has also been used in the treatment of <a href="../../../c/o/m/Combined_hyperlipidemia.html" title="Combined hyperlipidemia">combined hyperlipidemia</a>.<sup id="_ref-AMH2006_0" class="reference"><a href="#_note-AMH2006" title="">[1]</a></sup></p>
<p>In 2005, the PROVE IT-TIMI 22 trial compared 40mg/day pravastatin with 80mg/day atorvastatin.<sup id="_ref-Rouleau2005_0" class="reference"><a href="#_note-Rouleau2005" title="">[2]</a></sup> Taken directly from the results of the trial: "Standard treatment (statin) with a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor (pravastatin 40 mg/day) resulted in a 22% reduction in LDL cholesterol levels at 30 days compared with a 51% reduction with intensive therapy (atorvastatin 80 mg/day). At 2 years, a relative risk reduction of 16% (95% confidence interval, 5%-26%; P = 0.005) in the primary end point rate (death, myocardial infarction, documented unstable angina requiring hospitalization, coronary revascularization, or stroke) was seen in patients receiving intensive statin treatment compared with standard statin therapy. The benefit of intensive treatment was apparent as early as 30 days and was consistent over time. The PROVE IT-TIMI 22 data indicate that patients recently hospitalized for an ACS benefit from early and continued lowering of LDL cholesterol to levels substantially below current guideline recommendations."</p>
<p><a name="Available_forms" id="Available_forms"></a></p>
<h3><span class="editsection">[<a href="../../../a/t/o/Atorvastatin.html" title="Edit section: Available forms">edit</a>]</span> <span class="mw-headline">Available forms</span></h3>
<p><b>Atorvastatin calcium</b> tablets are currently marketed by <a href="../../../p/f/i/Pfizer.html" title="Pfizer">Pfizer</a> under the trade name <b>Lipitor</b>, in tablets (10, 20, 40 or 80 mg) for oral administration. Tablets are white, elliptical, and film coated. In some countries it may also be known as: <b>Sortis</b>, <b>Torvast</b>, <b>Totalip</b>, <b>Tulip</b>, <b>Xarator</b>, <b>Atorpic</b>, or <b>Liprimar</b>. It is also packaged in combination with other drugs, such as is the case with Pfizer's <a href="../../../c/a/d/Caduet.html" title="Caduet">Caduet</a>.</p>
<p><a name="Adverse_effects" id="Adverse_effects"></a></p>
<h3><span class="editsection">[<a href="../../../a/t/o/Atorvastatin.html" title="Edit section: Adverse effects">edit</a>]</span> <span class="mw-headline">Adverse effects</span></h3>
<div class="dablink"><i>For additional information see: <a href="../../../s/t/a/Statin.html#Safety" title="Statin">Statin#Safety</a></i></div>
<p>Common <a href="../../../a/d/v/Adverse_drug_reaction.html" title="Adverse drug reaction">adverse drug reactions</a> (≥1% of patients) associated with atorvastatin therapy include: <a href="../../../m/y/a/Myalgia.html" title="Myalgia">myalgia</a>, mild transient gastrointestinal symptoms, elevated hepatic <a href="../../../t/r/a/Transaminase.html" title="Transaminase">transaminase</a> concentrations, headache, insomnia, and/or dizziness.<sup id="_ref-AMH2006_1" class="reference"><a href="#_note-AMH2006" title="">[1]</a></sup></p>
<p><a href="../../../m/y/o/Myopathy.html" title="Myopathy">Myopathy</a> and <a href="../../../r/h/a/Rhabdomyolysis.html" title="Rhabdomyolysis">rhabdomyolysis</a> occur in &lt;0.1% of patients. Risk is increased in patients with <a href="../../../r/e/n/Renal_failure.html" title="Renal failure">renal impairment</a>, serious concurrent illness; and/or concomitant use of drugs which inhibit <a href="../../../c/y/p/CYP3A4_a5de.html" title="CYP3A4">CYP3A4</a>.<sup id="_ref-AMH2006_2" class="reference"><a href="#_note-AMH2006" title="">[1]</a></sup></p>
<p><a name="Patent_challenge" id="Patent_challenge"></a></p>
<h2><span class="editsection">[<a href="../../../a/t/o/Atorvastatin.html" title="Edit section: Patent challenge">edit</a>]</span> <span class="mw-headline">Patent challenge</span></h2>
<p>The size of the market for atorvastatin has prompted the <a href="../../../g/e/n/Generic_drug.html" title="Generic drug">generic drug</a> manufacturing company <a href="../../../r/a/n/Ranbaxy.html" title="Ranbaxy">Ranbaxy</a> to challenge the validity of some of Pfizer's <a href="../../../p/a/t/Patent.html" title="Patent">patents</a> in patent courts across the world. As of March 2007, courts had mostly upheld the validity of Pfizer's original patent for atorvastatin, which is due to expire in European territories in 2011 (but 2007 in Canada). However a later patent for the specific <a href="../../../e/n/a/Enantiomer.html" title="Enantiomer">enantiomer</a> of the atorvastatin formula that is medically useful, which would have given Pfizer longer protection, has fared less well. Although upheld in the <a href="../../../u/n/i/United_States_09d4.html" title="United States">United States</a><sup id="_ref-0" class="reference"><a href="#_note-0" title="">[3]</a></sup>, <a href="../../../s/p/a/Spain.html" title="Spain">Spain</a>, and <a href="../../../e/c/u/Ecuador.html" title="Ecuador">Ecuador</a>, the enantiomer patent has been declared invalid by courts in <a href="../../../a/u/s/Austria.html" title="Austria">Austria</a>, <a href="../../../a/u/s/Australia.html" title="Australia">Australia</a>, <a href="../../../c/a/n/Canada.html" title="Canada">Canada</a>, the <a href="../../../n/e/t/Netherlands.html" title="Netherlands">Netherlands</a> and the <a href="../../../u/n/i/United_Kingdom_5ad7.html" title="United Kingdom">United Kingdom</a><sup id="_ref-1" class="reference"><a href="#_note-1" title="">[4]</a></sup>.</p>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../a/t/o/Atorvastatin.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small">
<ol class="references">
<li id="_note-AMH2006">^ <a href="#_ref-AMH2006_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-AMH2006_1" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-AMH2006_2" title=""><sup><i><b>c</b></i></sup></a> Rossi S, editor. <a href="../../../a/u/s/Australian_Medicines_Handbook_0c4c.html" title="Australian Medicines Handbook">Australian Medicines Handbook</a> 2006. Adelaide: Australian Medicines Handbook; 2006. <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-9757919-2-3</a></li>
<li id="_note-Rouleau2005"><b><a href="#_ref-Rouleau2005_0" title="">^</a></b> Rouleau J., Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial. Am J Med. 2005 Dec;118 Suppl 12A:28-35. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16356805" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16356805">PMID 16356805</a>.</li>
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> BBC News, <a href="http://news.bbc.co.uk/1/hi/business/4542358.stm" class="external text" title="http://news.bbc.co.uk/1/hi/business/4542358.stm" rel="nofollow">Patent ruling hits Ranbaxy shares</a>, 19 December 2005</li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> Duncan Bucknell, <a href="http://www.duncanbucknell.com/Scorecard%20-%20Lipitor.html" class="external text" title="http://www.duncanbucknell.com/Scorecard%20-%20Lipitor.html" rel="nofollow">The global Lipitor patent scorecard</a>, retrieved 2007-03-03</li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../a/t/o/Atorvastatin.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.lipitor.com" class="external text" title="http://www.lipitor.com" rel="nofollow">Lipitor.com</a> – manufacturer's site</li>
<li><a href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203635.html" class="external text" title="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203635.html" rel="nofollow">MedlinePlus Drug information: Atorvastatin (Systemic)</a> – information from USP DI Advice for the Patient</li>
<li><a href="../../../c/h/e/Wikipedia%7EChemical_sources_67a4.html" title="Wikipedia:Chemical sources">Links to external chemical sources</a></li>
</ul>
<p><a name="Further_reading" id="Further_reading"></a></p>
<h2><span class="editsection">[<a href="../../../a/t/o/Atorvastatin.html" title="Edit section: Further reading">edit</a>]</span> <span class="mw-headline">Further reading</span></h2>
<ul>
<li>Maggon, Krishan. "Best-selling human medicines 2002-2004 (editorial)". 2005. Drug Discovery Today, 10(11):739-742. <a href="../../../d/i/g/Digital_object_identifier.html" title="Digital object identifier">DOI</a>:<a href="http://dx.doi.org/10.1016/S1359-6446(05)03468-9" class="external text" title="http://dx.doi.org/10.1016/S1359-6446(05)03468-9" rel="nofollow">10.1016/S1359-6446(05)03468-9</a></li>
<li><a href="http://www.lipitor.com/cwp/appmanager/lipitor/lipitorDesktop?_nfpb=true&amp;_pageLabel=prescribingInformation" class="external text" title="http://www.lipitor.com/cwp/appmanager/lipitor/lipitorDesktop?_nfpb=true&amp;_pageLabel=prescribingInformation" rel="nofollow">Lipitor: Prescribing Information.</a> (2004) Pfizer Ireland Pharmaceuticals.</li>
</ul>
<div class="NavFrame" style="clear:both;">
<div class="NavHead" style="background:#ccccff;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; position:absolute; width:auto; left:0.5em;"><a href="../../../s/t/a/Template%7EStatins_ca11.html" title="Template:Statins"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<span style="color: #002bb8;" title="Discussion about this template">d</span>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../s/t/a/Template%7EStatins_ca11.html" class="external text" title="http://en.wikipedia.org../../../s/t/a/Template%7EStatins_ca11.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
<b><a href="../../../s/t/a/Statin.html" title="Statin">Statins</a> (<a href="../../../a/t/c/ATC_code_C10_0350.html#C10AA_HMG_CoA_reductase_inhibitors" title="ATC code C10">C10AA</a>)</b></div>
<div class="NavContent" style="margin:0.5em; font-size:0.9em;">
<p><strong class="selflink">Atorvastatin</strong>, <a href="../../../c/e/r/Cerivastatin.html" title="Cerivastatin">Cerivastatin</a>, <a href="../../../f/l/u/Fluvastatin.html" title="Fluvastatin">Fluvastatin</a>, <a href="../../../l/o/v/Lovastatin.html" title="Lovastatin">Lovastatin</a>, <a href="../../../m/e/v/Mevastatin.html" title="Mevastatin">Mevastatin</a>, <a href="../../../p/i/t/Pitavastatin.html" title="Pitavastatin">Pitavastatin</a>, <a href="../../../p/r/a/Pravastatin.html" title="Pravastatin">Pravastatin</a>, <a href="../../../r/o/s/Rosuvastatin.html" title="Rosuvastatin">Rosuvastatin</a>, <a href="../../../s/i/m/Simvastatin.html" title="Simvastatin">Simvastatin</a></p>
</div>
</div>

<!-- 
Pre-expand include size: 32691 bytes
Post-expand include size: 12883 bytes
Template argument size: 2479 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/t/o/Atorvastatin.html">http://en.wikipedia.org../../../a/t/o/Atorvastatin.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Category</a>: <span dir='ltr'><a href="../../../s/t/a/Category%7EStatins_c64f.html" title="Category:Statins">Statins</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/t/o/Atorvastatin.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/t/o/Talk%7EAtorvastatin_9146.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Atorvastatin">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/a/t/o/Atorvastatin.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../es/a/t/o/Atorvastatina.html">Español</a>
	      </li>
	      	      <li>
	      <a href="../../../../hu/a/t/o/Atorvastatin.html">Magyar</a>
	      </li>
	      	      <li>
	      <a href="../../../../nl/a/t/o/Atorvastatine.html">Nederlands</a>
	      </li>
	      	      <li>
	      <a href="../../../../no/a/t/o/Atorvastatin.html">‪Norsk (bokmål)‬</a>
	      </li>
	      	      <li>
	      <a href="../../../../pl/a/t/o/Atorwastatyna.html">Polski</a>
	      </li>
	      	      <li>
	      <a href="../../../../fi/a/t/o/Atorvastatiini.html">Suomi</a>
	      </li>
	      	      <li>
	      <a href="../../../../th/%E0%B8%AD/%E0%B8%B0/%E0%B9%82/%E0%B8%AD%E0%B8%B0%E0%B9%82%E0%B8%97%E0%B8%A7%E0%B8%B2%E0%B8%AA%E0%B9%81%E0%B8%95%E0%B8%95%E0%B8%B4%E0%B8%99.html">ไทย</a>
	      </li>
	      	      <li>
	      <a href="../../../../zh/%E9%98%BF/%E6%89%98/%E4%BC%90/%E9%98%BF%E6%89%98%E4%BC%90%E4%BB%96%E6%B1%80.html">中文</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 14:51, 28 March 2007 by Wikipedia user <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>. Based on work by Wikipedia user(s) Ksaraf, <a href="../../../a/n/d/User%7EAndrew73_a1aa.html" title="User:Andrew73">Andrew73</a>, <a href="../../../j/t/c/User%7EJtclemens_f4ae.html" title="User:Jtclemens">Jtclemens</a>, Hubie59, <a href="../../../j/h/e/User%7EJheald_bb56.html" title="User:Jheald">Jheald</a>, <a href="../../../s/a/m/User%7ESam_Blacketer_4423.html" title="User:Sam Blacketer">Sam Blacketer</a>, <a href="../../../s/e/l/User%7ESelket_adc6.html" title="User:Selket">Selket</a>, <a href="../../../e/d/d/User%7EEddievos_1071.html" title="User:Eddievos">Eddievos</a>, Clarifythis, <a href="../../../d/a/v/User%7EDavidruben_76a6.html" title="User:Davidruben">Davidruben</a>, Mschneblin, Tins128, <a href="../../../b/e/e/User%7EBeetstra_df14.html" title="User:Beetstra">Beetstra</a>, <a href="../../../s/i/o/User%7ESiobhanHansa_73ec.html" title="User:SiobhanHansa">SiobhanHansa</a>, <a href="../../../a/m/i/User%7EAmitch_cbf2.html" title="User:Amitch">Amitch</a>, <a href="../../../o/h/n/User%7EOhnoitsjamie_fc14.html" title="User:Ohnoitsjamie">Ohnoitsjamie</a>, <a href="../../../b/u/b/User%7EBubba_hotep_ee80.html" title="User:Bubba hotep">Bubba hotep</a>, <a href="../../../v/e/c/User%7EVectro_bf83.html" title="User:Vectro">Vectro</a>, <a href="../../../k/a/i/User%7EKaiserbBot_1c36.html" title="User:KaiserbBot">KaiserbBot</a>, Tybalt01, Db714, <a href="../../../b/e/n/User%7EBenjah-bmm27_ebae.html" title="User:Benjah-bmm27">Benjah-bmm27</a>, <a href="../../../d/i/b/User%7EDiberri_3d04.html" title="User:Diberri">Diberri</a>, Rachattack, <a href="../../../t/e/c/User%7ETechelf_1565.html" title="User:Techelf">Techelf</a>, <a href="../../../f/l/a/User%7EFlaBot_747f.html" title="User:FlaBot">FlaBot</a>, <a href="../../../a/l/i/User%7EAlistairMcMillan_232b.html" title="User:AlistairMcMillan">AlistairMcMillan</a>, <a href="../../../e/d/g/User%7EEdgar181_7e9b.html" title="User:Edgar181">Edgar181</a>, <a href="../../../g/a/b/User%7EGabbe_a391.html" title="User:Gabbe">Gabbe</a>, <a href="../../../m/b/o/User%7EMboverload_cce2.html" title="User:Mboverload">Mboverload</a>, <a href="../../../r/e/x/User%7ERexNL_e4e0.html" title="User:RexNL">RexNL</a>, Drug Information, <a href="../../../g/r/a/User%7EGraemeL_c5a8.html" title="User:GraemeL">GraemeL</a>, <a href="../../../l/i/n/User%7ELinkspamremover_b617.html" title="User:Linkspamremover">Linkspamremover</a>, <a href="../../../y/u/r/User%7EYurikBot_b393.html" title="User:YurikBot">YurikBot</a>, <a href="../../../c/a/z/User%7ECazort_41d4.html" title="User:Cazort">Cazort</a>, <a href="../../../i/t/u/User%7EItub_c2f2.html" title="User:Itub">Itub</a>, <a href="../../../u/t/h/User%7EUthbrian_6843.html" title="User:Uthbrian">Uthbrian</a>, <a href="../../../t/a/v/User%7ETavilis_4b00.html" title="User:Tavilis">Tavilis</a>, <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>, <a href="../../../g/r/i/User%7EGrinBot_48c7.html" title="User:GrinBot">GrinBot</a>, <a href="../../../e/-/d/User%7EE-Detailing_b2ae.html" title="User:E-Detailing">E-Detailing</a>, <a href="../../../a/h/o/User%7EAhoerstemeier_88c8.html" title="User:Ahoerstemeier">Ahoerstemeier</a>, <a href="../../../j/a/m/User%7EJamesMLane_34be.html" title="User:JamesMLane">JamesMLane</a>, <a href="../../../c/e/y/User%7ECeyockey_fb55.html" title="User:Ceyockey">Ceyockey</a>, <a href="../../../g/j/e/User%7EGJeffery_6806.html" title="User:GJeffery">GJeffery</a>, <a href="../../../a/a/r/User%7EAaron_Brenneman_d498.html" title="User:Aaron Brenneman">Aaron Brenneman</a>, <a href="../../../k/o/o/User%7EKoopaTroopa211_15b4.html" title="User:KoopaTroopa211">KoopaTroopa211</a>, <a href="../../../d/i/r/User%7EDirk_Gently_4242.html" title="User:Dirk Gently">Dirk Gently</a>, <a href="../../../b/a/r/User%7EBartelmask_7f9a.html" title="User:Bartelmask">Bartelmask</a>, <a href="../../../s/i/m/User%7ESimonP_1010.html" title="User:SimonP">SimonP</a>, <a href="../../../g/j/e/User%7EGjeffery_8d88.html" title="User:Gjeffery">Gjeffery</a>, <a href="../../../w/h/o/User%7EWhosyourjudas_77b8.html" title="User:Whosyourjudas">Whosyourjudas</a>, <a href="../../../s/t/a/User%7EStarbane_1294.html" title="User:Starbane">Starbane</a> and <a href="../../../k/a/t/User%7EKate_3866.html" title="User:Kate">Kate</a> and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
